
ALS (Lou Gehrig's Disease)
Amyotrophic lateral sclerosis (ALS) is a degenerative disease that affects the brain and spinal cord. It causes a worsening loss of voluntary muscle control, which affects movements like talking, swallowing, and walking.
There is currently no cure for ALS. However, treatments are available that can reduce symptoms and may help people with ALS to live longer.
ALS eventually results in loss of life. People typically live with ALS for 2 to 5 years. Some people will live longer.
There is currently no cure for ALS. However, treatments are available that can reduce symptoms and may help people with ALS to live longer.
The famous baseball player Lou Gehrig developed symptoms of the condition in the 1930s, and that's why it's also known as Lou Gehrig's disease.
What are the causes of ALS?
ALS can be classified as either sporadic or familial. Most cases are sporadic. That means no specific cause is known.
Familial ALS happens when the condition is inherited from a parent. Only about 5% to 10% of ALS cases are familial.
Other causes of ALS aren't well understood. Some factors that scientists think might contribute to ALS include:
free radical damage
imbalances in the chemical messenger glutamate
protein abnormalities, like misfolding
nerve inflammation
Military veterans are thought to be at higher risk for ALS, though the reasons for this are unclear. Some research suggests that smoking is a risk factor for ALS. Research on other possible environmental triggers is ongoing.
Demographic factors
Age: The likelihood of receiving an ALS diagnosis increases with age. The onset of symptoms in ALS usually occurs between the ages of 55 and 75, although symptoms can occur earlier.
Sex: According to statistics that group people into male and female categories, ALS is more common among males than females.
Race and ethnicity: Research suggests that white people are more likely to receive an ALS diagnosis than people of other racial or ethnic groups. According to the National Organization for Rare Diseases, more studies are needed to understand who's affected by ALS globally.
How often does ALS occur?
Every year, about 5,000 people in the United States receive an ALS diagnosis. Around 30,000 people in the U.S. are currently living with the condition. ALS affects people in all racial, social, and economic groups.
A 2016 study suggests that ALS is becoming more common. This may be because the population is aging.
What are the symptoms of ALS?
Both sporadic and familial ALS are associated with a progressive loss of motor neurons. As motor neurons become damaged, a person with ALS will start to have difficulty with voluntary movements in their limbs, mouth, or throat.
There are two main types of ALS. Each one is associated with a different set of symptoms at the time of diagnosis.
Limb onset
Around 70% of people with ALS have what's known as 'limb onset' ALS. This means that symptoms first appear in the arms or legs.
Symptoms in the arms (upper limb onset) include:
weakness in hands
stiff arms or hands
cramps in arms or hands
loss of dexterity, fumbling, or dropping objects
Symptoms in the legs (lower limb onset) include:
trouble with walking or running
tripping or stumbling
difficulty lifting the front half of the foot when walking, known as foot drop
Early symptoms are usually in either the arms or the legs, not both. Limb onset ALS usually progresses more slowly than other types.
Bulbar onset
'Bulbar onset' ALS is less common. In this type, ALS first affects a part of the brainstem known as the corticobulbar area. Symptoms include difficulty with speech and swallowing and muscle spasms in the face or throat.
There are also rare sub-types of ALS that are defined by other symptoms present at the time of diagnosis. These include respiratory onset ALS when difficulties with the breathing muscles are the earliest sign of illness.
Upper and lower motor neurons
You have two main types of motor neurons in your body: upper motor neurons and lower motor neurons. They work together to allow your brain to communicate with your muscles to make voluntary movements possible.
For example, when you decide to move your finger, your upper motor neurons first send signals from your brain to your spinal cord. Then, lower motor neurons carry signals from the spinal cord to the muscles that move your finger.
By definition, ALS affects both upper and lower motor neurons. But the condition may start by affecting one type more than the other, either the upper or the lower. Each type can result in different symptoms.
Symptoms of upper motor neuron disease include:
involuntary rhythmic muscle contractions, known as clonus
rigid muscles (spacticity)
overactive reflexes
Symptoms of lower motor neuron disease include:
limp (flaccid) muscles
muscle atrophy
spontaneous twitching
Weakness happens with both types of motor neuron disease.
Progression
The earliest symptoms of ALS may include small muscle twitches in your:
mouth
throat
face
limbs
But it's typical to notice muscle twitches from time to time. They're usually not a cause for concern. In early ALS, muscle twitches are likely to become more frequent over time.
Other early signs of ALS may include difficulty performing some everyday tasks. This could mean difficulty climbing stairs or getting up from a chair. It's also possible to have difficulty speaking or swallowing, or weakness in the arms, hands, or legs. You may also notice cramping.
Early symptoms tend to be asymmetrical, which means they only happen on one side.
As the condition progresses, the symptoms generally spread to both sides of the body. Muscle weakness, weight loss, and muscle atrophy are common. In the late stages of ALS, paralysis of the muscles occurs. Paralysis means the complete loss of voluntary movements.
ALS doesn't affect your senses, like seeing or hearing. Bowel and bladder control can be affected in later stages of the disease.
ALS is a terminal illness, which means that it eventually results in loss of life. People typically live with ALS for 2 to 5 years. Some people will live longer. Approximately 20% of people live with ALS for over 5 years, and 10% for more than 10 years. The most common life-ending event in ALS is respiratory failure.
What body systems are affected by ALS?
While ALS specifically affects the motor neurons of the brain and spinal cord, other body systems that rely on these neurons will be impacted as the disease progresses. As the ability to control voluntary muscles declines, functions like breathing, speaking, and moving are affected.
ALS progresses differently for everyone. A doctor or neurologist who specializes in the condition can help those with ALS understand what to expect.
ALS complications
ALS can affect many aspects of daily functioning. These include:
Respiratory system and breathing
ALS causes the muscles controlling breathing to weaken over time. Breathing is likely to become more laborious. As the respiratory system weakens, the risk of pneumonia increases. Eventually, as the condition progresses, a ventilator may be required to assist breathing.
Speaking
Muscles in the mouth, jaw, and throat tend to lose strength and mobility. Because of this, it can become hard for a person with ALS to make themselves understood when speaking. In severe cases, some people lose the ability to produce speech.
Eating
ALS usually affects chewing and swallowing, making eating more difficult. Choking is a possible complication.
Weight loss and malnutrition
Because eating can become challenging and ALS may cause people to burn calories more quickly, it's common to experience rapid weight loss and undernutrition.
Moving
Standing and walking will generally become more difficult over time. Some people will have trouble moving their arms.
The changes will happen differently for each person. But in general, more muscles will be affected, and the loss of function will become more severe as ALS progresses. Pressure sores are a possible complication as moving becomes harder.
Cognition
ALS causes cognitive changes in up to 50% of cases. These changes can affect language and executive function. Dementia is possible but less common. In ALS, physical changes to the brain can also cause uncontrollable laughing and crying, known as emotional lability.
Some variants of ALS are more commonly associated with cognitive changes, like ALS-frontotemporal spectrum disorder.
Mood
It's typical to feel a range of emotions when coping with a serious illness. Managing symptoms and life changes caused by ALS can be emotionally difficult. For some people with ALS, these changes can result in anxiety and depression.
If you're living with ALS and notice changes in your daily functioning, talk with your doctor and healthcare team. Medication and support can help maintain quality of life, even as symptoms progress.
Does ALS affect thinking?
Cognitive changes are common among people with ALS, affecting between 30% and 50% of those with the disease. The changes are usually classified as mild to moderate. Difficulty with reasoning, planning, and slowed thinking are among the most common cognitive symptoms of ALS.
Behavioral changes like emotional lability (uncontrollable laughing and crying) are also possible, even if cognition is otherwise unaffected.
It's less common, but ALS-related dementia can also occur if there's cell degeneration in the frontotemporal regions of the brain.
How is ALS diagnosed?
ALS is usually diagnosed by a neurologist. There's no specific test for ALS. The process of establishing a diagnosis can take anywhere from weeks to months.
An ALS diagnosis may be considered if someone has nerve and muscle health concerns that get worse over time. A doctor will watch for increasing symptoms like:
muscle weakness
muscle atrophy
twitching
cramps
rigid tissue, known as contracture
These symptoms can also be caused by a number of other conditions. Therefore, a diagnosis requires your doctor to rule out other health concerns. This is done with a series of diagnostic tests, including:
an EMG test to evaluate the electrical activity of your muscles
nerve conduction studies to test your nerve function
an MRI scan that shows which parts of your nervous system are affected
blood tests to evaluate your general health and nutrition
Genetic tests may also be useful for people with a family history of ALS.
How is ALS treated?
Many different areas of functioning can be affected as control over voluntary movements declines. Treatments and supports are available to address most symptoms.
A team of doctors and specialists often work together to treat people with ALS. Specialists involved in the ALS team might include:
a neurologist who is skilled in the management of ALS
a doctor who specializes in physical medicine and rehabilitation (physiatrist)
a dietitian
a gastroenterologist
an occupational therapist
a respiratory therapist
a speech therapist
a social worker
a psychologist
a pastoral care professional
a doctor who specializes in palliative care
Family members should talk with people with ALS about their care. As the condition progresses, some people may need support when making medical decisions.
Connecting with a local ALS society can help people with ALS and their families access resources and support.
Assistive devices
Assistive devices like braces, mattresses, and wheelchairs can reduce pain by supporting the body in a more comfortable position.
Some people may need nutritional support, like a feeding tube (enteral feeding).
As speech becomes more difficult, communication tools provide another way to express thoughts and needs. Options include communication boards and electronic assistive communication devices.
If you're considering assistive devices, it's best to consult with your healthcare team to find the right options for you.
Medications
Two medications — riluzole (Rilutek, Tiglutik, Exservan) and edaravone (Radicava) — are approved for the treatment of ALS.
Riluzole appears to reduce a particular kind of nerve damage called glutamate-induced excitotoxicity. It can slow the progression of respiratory symptoms and prolong life by several months.
Edaravone (Radicava) appears to help with ALS symptoms by reducing oxidative stress. It can slow the progression of ALS, especially for those in the early stages of the condition.
Other medications may be used to treat the symptoms of ALS. Some of these medications include:
mexiletine and baclofen, for muscle cramps and spasms
nonsteroidal anti-inflammatory drugs (NSAIDs) and morphine, for pain management
dextromethorphan/quinidine (Nuedexta), for emotional lability
As of 2020, more than 40 potential new medications for ALS are being studied. Clinical trials for stem cell therapy are also underway. But stem cell therapy hasn't yet been proven to be an effective treatment for ALS.
Nonmedical treatments
Your doctor may recommend therapies like heat treatments, exercise, and physical therapy to reduce ALS symptoms. These should only be undertaken as directed by your healthcare team.
Massage, meditation, and other complementary and alternative therapies may also help with relaxation and comfort. Before starting any nonmedical treatment, it's important to discuss it with your doctor.
What is the long-term outlook for people with ALS?
There's currently no cure for ALS. But medication and supportive care can improve quality of life. Make it a priority to discuss new or changing symptoms with your healthcare team. Proper treatment and support can help those with ALS live happily and comfortably for as long as possible.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
32 minutes ago
- Yahoo
Gerard C. Murphy Gerry Murphy was born in Brooklyn, New York
Jul. 11—Gerard C. Murphy Gerry Murphy was born in Brooklyn, New York on May 14, 1947 and left this world on June 18, 2025 in Albuquerque, New Mexico. He graduated from Fordham College, Magna Cum Laude, with a B.A. in Mathematics, and also received an M.S. in Mathematics from Polytechnic Institute of New York where he completed all course work towards a Ph.D. He taught Math at the Hackley School in Tarry-town, New York from 1971 to 1990 where he became Chairman of the Department and was awarded the Wallace McLean Chair in Math and Science. He then taught Math at Albuquerque Academy from 1990 to 2011. He loved teaching, skiing, playing tennis, traveling, reading, taking photographs, music, and was a member of the Zen Buddhist community in New York. Gerry will always be remembered as smart and very funny. He will be greatly missed by his family and friends. He leaves behind his wife of 56 years, Doreen Mazza Murphy; his sister, Virginia Murphy of Durham, England and her family; and his brother-in-law, Tony Mazza and wife Mona Look-Mazza of Aspen, Colorado. He is the son of the late Francis Murphy and Dorothy Colvell Murphy and the nephew of the late Virginia Colvell, all of Brooklyn, New York. There will be a private graveside service at Gate of Heaven Cemetery in Hawthorne, New York.
Yahoo
38 minutes ago
- Yahoo
Why Clover Health (CLOV) Shares Are Trading Lower Today
Shares of health insurance company Clover Health (NASDAQ:CLOV) fell 4.8% in the afternoon session after a filing revealed that the company's CEO, Wai Conrad, sold a portion of his holdings. According to a regulatory filing on July 11, 2025, CEO Wai Conrad sold 15,203 shares of Class A Common Stock on July 8 for a total of approximately $49,561. The transactions were made at prices ranging from $3.25 to $3.27 per share. While the sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell a predetermined number of shares at a predetermined time, the news can still create unease among investors. Insider selling, even when planned, is often scrutinized by the market for any signals about a company's future prospects, contributing to negative pressure on the stock price. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Clover Health? Access our full analysis report here, it's free. Clover Health's shares are extremely volatile and have had 45 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Clover Health is down 7.2% since the beginning of the year, and at $2.91 per share, it is trading 39.7% below its 52-week high of $4.82 from January 2025. Investors who bought $1,000 worth of Clover Health's shares 5 years ago would now be looking at an investment worth $261.71. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Why Owens & Minor (OMI) Shares Are Sliding Today
Shares of medical supply and logistics company Owens & Minor (NYSE:OMI) fell 3% in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White House announced plans to impose a 35% tariff on Canadian imports, sparking renewed fears of a trade war. This news prompted a sell-off across major U.S. indexes, including the S&P 500 and the Dow Jones Industrial Average, as investors grew concerned about the potential economic impact of escalating protectionist policies. The healthcare sector is especially vulnerable to such tensions due to its deeply integrated supply chains with Canada for pharmaceuticals and medical devices, meaning increased costs and potential disruptions. Additionally, ongoing U.S. policy headwinds aimed at lowering drug prices and specific corporate challenges, like those faced by UnitedHealth Group, further compounded the sector's decline. As a result, the Health Care SPDR ETF (XLV) fell 1.0%, underperforming even as major indices pared some losses. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Owens & Minor? Access our full analysis report here, it's free. Owens & Minor's shares are extremely volatile and have had 44 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Owens & Minor is down 37.3% since the beginning of the year, and at $8.06 per share, it is trading 51.1% below its 52-week high of $16.48 from July 2024. Investors who bought $1,000 worth of Owens & Minor's shares 5 years ago would now be looking at an investment worth $1,095. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.